Company announcement – No. 6 / 2022
Zealand Pharma Hosts Conference Call on
Presenting during the call will be President and Chief Executive Officer
+45 32 720 417 | |
+80 711 246 | |
+33 (0) 170 700 781 | |
+31 (0) 207956614 | |
+44 (0) 844 481 9752 | |
+1 646 741 3167 | |
International................................ | +44 (0) 2071 928338 |
Confirmation Code: ................ | 9554999 |
A live audio webcast of the call, including an accompanying slide presentation, will be available via the following link, https://edge.media-server.com/mmc/p/34a8yoe2, and will be accessible on the Investor section of Zealand’s website (www.zealandpharma.com/investor). Due to increased demand of conference call services, it could take longer to be connected to the call. Participants are advised to register for the webcast 30 minutes before the scheduled start, if possible. A recording of the event and a transcript will be available on the Investor section of Zealand’s website after the call.
# # #
About
Zealand was founded in 1998 in
Forward-Looking Statements
This announcement may contain forward-looking statements, including “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, that are based on the beliefs and assumptions and on information currently available to management of Zealand, including with respect to the company’s anticipated revenue and expenses for 2021 and potential product approval by the FDA. All statements other than statements of historical fact contained in this announcement are forward-looking statements, including statements regarding the anticipated final terms of the Investment. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Zealand's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the "Risk Factors" section of the Zealand's Annual Report on Form 20-F for the year ended
For further information, please contact:
Zealand Pharma Investor Relations |
investors@zealandpharma.com |
Zealand Pharma Media Relations |
media@zealandpharma.com |
Source:
2022 GlobeNewswire, Inc., source